Boundless Bio, Inc. - Common Stock (BOLD)

Boundless Bio just reported results for the first quarter of 2024.

Gainers HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market session. The company's market cap stands at $5.6 million. Boundless Bio (NASDAQ:BOLD) shares rose 62.85% to $2.28. The

Let's have a look at the gap up and gap down stocks in today's session.

BOLD stock results show that Boundless Bio beat analyst estimates for earnings per share the second quarter of 2024.

Shares of Boundless Bio fell almost 10% after raising about $100 million in the company's initial public offering. Bayer is one of the biggest investors for the therapeutics company.